Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioNTech
BNTX
|
+$1.21B |
| 2 |
Sea Limited
SE
|
+$842M |
| 3 |
Okta
OKTA
|
+$819M |
| 4 |
XYZ
Block Inc
XYZ
|
+$749M |
| 5 |
Mercado Libre
MELI
|
+$656M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$929M |
| 2 |
Union Pacific
UNP
|
+$677M |
| 3 |
Spotify
SPOT
|
+$575M |
| 4 |
RingCentral
RNG
|
+$499M |
| 5 |
Amazon
AMZN
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.98% |
| 2 | Consumer Discretionary | 23.1% |
| 3 | Communication Services | 15.59% |
| 4 | Healthcare | 8.54% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Pembina Pipeline
PBA
$28.2B
| $26.9M | 0.02% |
848,004
-211,794
| -20% | -$6.68M |
|
327
Eastern Bankshares
EBC
$5.37B
| $26.5M | 0.02% |
1,307,552
-71,228
| -5% | -$1.36M |
|
328
Diamondback Energy
FANG
$54.2B
| $26.5M | 0.02% |
279,427
-5,351
| -2% | -$430K |
|
|
DCP
329
DELISTED
DCP Midstream, LP
DCP
| $26.4M | 0.02% |
936,597
-9,165
| -1% | -$253K |
|
330
Freeport-McMoran
FCX
$96.9B
| $26.3M | 0.02% |
807,603
-160,443
| -17% | -$5.65M |
|
331
Oshkosh
OSK
$9.64B
| $25.8M | 0.02% |
251,877
+4,811
| +2% | +$553K |
|
|
ZEN
332
DELISTED
ZENDESK INC
ZEN
| $25.5M | 0.02% |
219,494
-38,159
| -15% | -$4.93M |
|
333
Ero Copper
ERO
$3.02B
| $25.2M | 0.02% |
1,420,854
+773
| +0.1% | +$14.8K |
|
334
Goosehead Insurance
GSHD
$2.37B
| $25.1M | 0.02% |
164,489
-44,285
| -21% | -$5.97M |
|
|
IAA
335
DELISTED
IAA, Inc. Common Stock
IAA
| $25M | 0.02% |
457,533
+7,331
| +2% | +$406K |
|
336
Yeti Holdings
YETI
$3.9B
| $24.9M | 0.02% |
290,246
-49,999
| -15% | -$4.84M |
|
337
Prestige Consumer Healthcare
PBH
$2.47B
| $24.8M | 0.02% |
442,338
+68,525
| +18% | +$3.76M |
|
338
Ryan Specialty Holdings
RYAN
$5.72B
| $24.8M | 0.02% |
+731,509
| New | +$23.1M |
|
339
Repligen
RGEN
$8.34B
| $24.7M | 0.02% |
85,582
+2,948
| +4% | +$756K |
|
|
PXD
340
DELISTED
Pioneer Natural Resource Co.
PXD
| $24.4M | 0.02% |
146,578
+1,146
| +0.8% | +$173K |
|
|
BRKL
341
DELISTED
Brookline Bancorp
BRKL
| $24M | 0.02% |
1,574,285
-60,873
| -4% | -$883K |
|
342
Sprout Social
SPT
$527M
| $23.8M | 0.02% |
195,158
-133,691
| -41% | -$14.5M |
|
343
Fate Therapeutics
FATE
$305M
| $22.7M | 0.01% |
383,714
-360,278
| -48% | -$28.3M |
|
|
CDMO
344
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $22.7M | 0.01% |
1,053,365
+242,318
| +30% | +$5.85M |
|
345
Canadian National Railway
CNI
$76.9B
| $22.7M | 0.01% |
196,452
+159,342
| +429% | +$17.6M |
|
346
JD.com
JD
$44.4B
| $22.4M | 0.01% |
+310,027
| New | +$22.9M |
|
|
NARI
347
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $22.3M | 0.01% |
+275,327
| New | +$23.1M |
|
348
Darden Restaurants
DRI
$23.3B
| $22.2M | 0.01% |
146,826
-6,488
| -4% | -$954K |
|
349
Huron Consulting
HURN
$2.41B
| $21.8M | 0.01% |
419,128
+86,825
| +26% | +$4.23M |
|
350
Veracyte
VCYT
$3.72B
| $21.8M | 0.01% |
468,760
+8,315
| +2% | +$363K |
|
Similar funds
Jennison Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Jennison Associates held 761 positions worth $155B, up 2.5% from $151B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jennison Associates's Q3 2021 filing shows 96 new, 254 increased, 288 reduced and 100 closed positions. Its largest new stake was ZoomInfo Technologies: 3,206,107 shares worth $196M. The largest sale was Match Group, an estimated $929M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2021 buy was ZoomInfo Technologies: 3,206,107 shares worth $196M.
- Jennison Associates added most to BioNTech in Q3 2021, an estimated $1.21B increase.
- Jennison Associates's biggest Q3 2021 reduction was Match Group, cutting an estimated $929M.
- Jennison Associates fully exited Zoom in Q3 2021, selling an estimated $285M.
- Jennison Associates's ten largest holdings make up 38% of its $155B portfolio in Q3 2021.
- Jennison Associates opened 96 new positions and closed 100 in Q3 2021.
- Jennison Associates's portfolio value rose 2.5% quarter-over-quarter to $155B.
Based on Jennison Associates's 13F filing for Q3 2021, filed 9 Nov 2021.